Back to Results
First PageMeta Content
Birt–Hogg–Dubé syndrome / Gastrointestinal cancer / Folliculin / Birt / BHD / Renal cell carcinoma / Transforming growth factor beta / Pneumothorax / Cancer / Medicine / Health / Rare diseases


Birt-Hogg-Dubé Newsletter September 2010 Vol.8, No.1 You are receiving this email because you have expressed an interest in BHD. We hope you will enjoy this and future
Add to Reading List

Document Date: 2011-03-17 20:08:21


Open Document

File Size: 216,71 KB

Share Result on Facebook

Company

European BHD / The Myrovlytis Trust / /

Country

Netherlands / United Kingdom / /

/

Facility

University of Pennsylvania Medical School / University Hospital Maastricht / Imperial College / Cardiff University / /

IndustryTerm

therapy for BHD Syndrome / /

MedicalCondition

familial and sporadic colorectal cancer / Tumor / BHD-associated renal tumours / recurrent pneumothorax / BHD Syndrome / familial colorectal cancer / spontaneous pneumothorax / parotid oncocytoma / Disease / tumour / FLCN-null renal cancer / recurrent tumors / Recurrent spontaneous pneumothorax / renal cell carcinoma / Mol Cancer / suspected Birt-Hogg-Dubé syndrome / left kidney carcinoma / Birt-Hogg-Dubé syndrome / female BHD Syndrome / /

MedicalTreatment

gene therapy / /

Organization

Genetic Alliance UK / University of Pennsylvania Medical School and Desteny / Cardiff University / Imperial College London / Human Fertilisation and Embryology Authority / the University of Pennsylvania / Myrovlytis Trust Birt-Hogg-Dubé Family Alliance / /

Person

Vera Krymskaya / Maurice van Steensel / Richard Harbottle / Andrew Tee / /

Position

editor / Associate Professor of Medicine / /

Technology

gene therapy / apoptosis / /

URL

www.BHDSyndrome.org / /

SocialTag